Denali Therapeutics (DNLI) Prepaid Assets (2017 - 2026)

Denali Therapeutics (DNLI) has 10 years of Prepaid Assets data on file, last reported at $35.1 million in Q1 2026.

• On a quarterly basis, Prepaid Assets fell 42.24% year-over-year to $35.1 million in Q1 2026; TTM through Mar 2026 was $35.1 million, a 42.24% decrease from a year earlier, with the FY2025 full-year figure at $32.8 million, up 2.1% from the prior year.
• Prepaid Assets for Q1 2026 stood at $35.1 million, up from $32.8 million in the prior quarter.
• Over the last five years, Prepaid Assets for DNLI reached as high as $60.7 million in Q1 2025 and fell as low as $29.6 million in Q4 2023.
• Historically, Prepaid Assets has averaged $35.9 million across 5 years, with a median of $33.6 million in 2023.
• Across the five-year window, Prepaid Assets jumped 184.33% in 2022 and sank 42.24% in 2026, its largest moves.
• Year by year, Prepaid Assets stood at $36.1 million in 2022, then declined by 17.94% to $29.6 million in 2023, then grew by 8.37% to $32.1 million in 2024, then gained by 2.1% to $32.8 million in 2025, then climbed by 6.98% to $35.1 million in 2026.
• Per Business Quant data, the three most recent Prepaid Assets figures were $35.1 million in Q1 2026, $32.8 million in Q4 2025, and $34.4 million in Q3 2025.